Literature DB >> 25402417

Post transplant CMV-specific T-cell immune reconstitution in the absence of global T-cell immunity is associated with a high risk of subsequent virus reactivation.

S-K Tey1, M P Davenport2, G R Hill3, G A Kennedy4, S T Durrant5, R Khanna6, D Cromer2.   

Abstract

Mesh：

Year:  2014        PMID： 25402417     DOI： 10.1038/bmt.2014.265

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study.

Authors:  Jan W Gratama; Michael Boeckh; Ryotaro Nakamura; Jan J Cornelissen; Rik A Brooimans; John A Zaia; Stephen J Forman; Karl Gaal; Kurtis R Bray; Gail H Gasior; Christopher S Boyce; Linda A Sullivan; Paula C Southwick
Journal:  Blood       Date:  2010-05-27       Impact factor: 22.113

2.  Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection.

Authors:  Carlos Solano; Isana Benet; María A Clari; José Nieto; Rafael de la Cámara; Javier López; Juan C Hernández-Boluda; María J Remigia; Isidro Jarque; María L Calabuig; Ana Garcia-Noblejas; Juan Alberola; Amparo Tamarit; Concepción Gimeno; David Navarro
Journal:  Haematologica       Date:  2008-07-04       Impact factor: 9.941

3.  Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.

Authors:  Jan W Gratama; Rik A Brooimans; Bronno van der Holt; Kees Sintnicolaas; Gerard van Doornum; Hubertus G Niesters; Bob Löwenberg; Jan J Cornelissen
Journal:  Cytometry B Clin Cytom       Date:  2008-07       Impact factor: 3.058

4.  Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants.

Authors:  Daniele Lilleri; Giuseppe Gerna; Chiara Fornara; Laura Lozza; Rita Maccario; Franco Locatelli
Journal:  Blood       Date:  2006-04-13       Impact factor: 22.113

5.  Cellular immune function monitoring after allogeneic haematopoietic cell transplantation: evaluation of a new assay.

Authors:  M Israeli; T Klein; C Herscovici; R Ram; O Shpilberg; B Sredni; M Yeshurun
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

6.  Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Authors:  Karim Sacre; Stéphanie Nguyen; Claire Deback; Guislaine Carcelain; Jean-Paul Vernant; Véronique Leblond; Brigitte Autran; Nathalie Dhedin
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

7.  Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity.

Authors:  Michael Boeckh; Wendy Leisenring; Stanley R Riddell; Raleigh A Bowden; Meei-Li Huang; David Myerson; Terry Stevens-Ayers; Mary E D Flowers; Terri Cunningham; Lawrence Corey
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

8.  Estimating cytomegalovirus growth rates by using only a single point.

Authors:  Deborah Cromer; Siok-Keen Tey; Rajiv Khanna; Miles P Davenport
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

9.  Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.

Authors:  Daniele Lilleri; Chiara Fornara; Antonella Chiesa; Daniela Caldera; Emilio Paolo Alessandrino; Giuseppe Gerna
Journal:  Haematologica       Date:  2008-02       Impact factor: 9.941

10.  Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications.

Authors:  Siok-Keen Tey; Glen A Kennedy; Deborah Cromer; Miles P Davenport; Susan Walker; Linda I Jones; Tania Crough; Simon T Durrant; James A Morton; Jason P Butler; Ashish K Misra; Geoffrey R Hill; Rajiv Khanna
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240
View more
  2 in total

1.  Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.

Authors:  Corey Smith; Rebekah M Brennan; Siok-Keen Tey; Mark J Smyth; Scott R Burrows; John J Miles; Geoffrey R Hill; Rajiv Khanna
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

Review 2.  Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Authors:  Lauren Stern; Barbara Withers; Selmir Avdic; David Gottlieb; Allison Abendroth; Emily Blyth; Barry Slobedman
Journal:  Front Microbiol       Date:  2019-05-28       Impact factor: 5.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.